Comment
doi: 10.1002/jbmr.4318.
Epub 2021 May 5.
Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing
Affiliations
- PMID: 33950530
- DOI: 10.1002/jbmr.4318
Item in Clipboard
Comment
Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing
J Bone Miner Res.
2021 Dec.
Free article
No abstract available
Comment in
-
Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing.J Bone Miner Res. 2021 Dec;36(12):2455-2456. doi: 10.1002/jbmr.4317. Epub 2021 May 24. J Bone Miner Res. 2021. PMID: 34030212 Free PMC article. No abstract available.
Comment on
-
Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia.J Bone Miner Res. 2021 Feb;36(2):262-270. doi: 10.1002/jbmr.4184. Epub 2020 Nov 4. J Bone Miner Res. 2021. PMID: 32967046 Free PMC article. Clinical Trial.
-
Burosumab for the Treatment of Tumor-Induced Osteomalacia.J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12. J Bone Miner Res. 2021. PMID: 33338281 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
